Hard technology continues to heat up, with Zhijian Power raising a total of 2 billion yuan in financing over half a year.

Over the past week, the dual core pattern of technology and manufacturing, as well as healthcare, has continued to strengthen. The consumer services sector also showed impressive financing performance, with large transactions in segments such as embodied intelligence, brain-computer interfaces, AI video generation, and cell therapy.

In the technology and manufacturing sectors, large-scale investment and financing deals have been concentrated: Embodied intelligence company Jizhan Power completed a 2 billion RMB Series A funding round, attracting well-known investors including Yuanjing Capital, Sequoia China, and strategic investors like Tencent and Alibaba; MagicLab, also in embodied intelligence, completed over 500 million RMB in Series A funding, simultaneously launching a hundred-billion ecosystem fund, with core products including humanoid and quadruped robots already mass-produced and delivered; AI video generation company AiShi Technology completed a $300 million Series C funding round, focusing on building an AIGC visual multimodal algorithm platform covering various vertical application scenarios; Generative AI and simulation data provider Guanglun Intelligence secured 1 billion RMB in Series A+ funding, using a “generative AI + simulation technology” integrated model to bridge data gaps in the AI era.

Additionally, companies like BlueStar Light Domain, Zero One Automotive, Huaxin Cheng, and YaoShi Lithium Battery have each completed over 100 million RMB in funding, covering segments such as satellite laser communication, intelligent driving new energy heavy trucks, chip design, and solid-state batteries. Capital continues to focus on core technologies that are autonomous and controllable, full industry chain deployment, and scenario-based implementation, with independent innovation becoming the key development direction for enterprises after financing.

The healthcare sector maintains a steady and positive financing trend, with transactions in specialized segments such as brain diagnosis and treatment, cell therapy, and cardiac electrophysiology: Brain-computer interface R&D company Ladder Medical completed 500 million RMB in strategic financing; cardiac electrophysiology company AicoPulse completed over 100 million RMB in Series B funding; next-generation universal spot cell therapy developer Aike Biological completed over 100 million RMB in Series A+++ funding; anti-aging and metabolic drug developer MetaNovas completed Series A+ and A++ rounds.

According to incomplete statistics from 21 Venture Capital, from March 9 to March 15, 2026, a total of 50 financing events were disclosed in the domestic primary market. Among these, 27 disclosed the amount and currency, with a total disclosed financing scale exceeding 11 billion RMB.

01. Multiple financings completed in the technology, manufacturing, and healthcare sectors

This week’s financing mainly concentrated in the technology, manufacturing, healthcare, and consumer services sectors. The technology and manufacturing sector completed 36 deals, covering segments such as embodied intelligence and intelligent driving; healthcare completed 6 deals, including cell therapy and brain diagnosis equipment, demonstrating strong development potential.

02. Jiangsu Province, Guangdong Province, and Beijing completed multiple financings

From the regional distribution of the disclosed invested companies, this week’s financings mainly occurred in Jiangsu Province, Guangdong Province, and Beijing, with 15, 11, and 7 deals respectively.

03. Which investment institutions are most active

In terms of institutional investment activity, Songhe Capital and Fangguang Capital were particularly active this week, with most deals concentrated in the technology and manufacturing sectors.

Below is a summary of investment and financing information:

Healthcare

MetaNovas completes A+ and A++ rounds of financing

On March 9, MetaNovas (Yuanxing Zhiyao) announced the completion of A+ and A++ rounds of financing, jointly invested by Fuhua Capital, Hillhouse Capital, and Kangaroo Mom Group, among others in the consumer health industry. Previously, the Series A round was led by Hillhouse Ventures and Baodao Venture Capital, with follow-on investments from Yu Yucheng.

MetaNovas is a developer of anti-aging and metabolic drugs, aiming to combine AI with life sciences, using deep learning, knowledge graphs, and multi-omics analysis to understand complex biological networks, decipher disease mechanisms, and develop products such as anti-aging agents and treatments for neurodegenerative and metabolic diseases.

Aike Biological completes over 100 million RMB in Series A+++ financing

On March 9, Aike Biological, a developer of next-generation universal spot cell therapy drugs, completed over 100 million RMB in Series A+++ funding, invested by WoJie Capital, Zhi Yi Investment, and Lianxin Capital. Previously, Zhi Yi Investment and West Lake Venture Capital participated in earlier rounds.

Aike Li Yuan is a new generation of universal spot cell therapy developer, adhering to the principle of “clinical demand-oriented, patient-centered drug development.” The company has deep technical expertise in iPSC reprogramming, gene editing, and stem cell differentiation, achieving a series of original breakthroughs in the iPSC field.

Zhongke Boxrui completes several tens of millions RMB in Series B financing

On March 10, Zhongke Boxrui, a brain diagnosis and treatment device developer, announced the completion of several tens of millions RMB in Series B funding, led by Sanze Venture Capital. Previous investors include Zhangjiagang Industrial Capital Center and Jinxin Capital.

Based on NIRS (Near Infrared Spectroscopy) principles and leveraging the technical expertise accumulated by the Brain Network Research Center of the Institute of Automation, Chinese Academy of Sciences, the company developed non-invasive, multi-channel, real-time monitoring portable brain oxygen monitors and wearable wireless brain oxygen headbands.

Ladder Medical completes 500 million RMB in Series C financing

On March 12, Ladder Medical, a brain-computer interface R&D company, announced a strategic financing of 500 million RMB led by Alibaba, with Guotou Chuanghe and other investors participating. Long-term shareholders Tencent, Yuanlai Capital, Aobo Capital, Yuanhe Yuan Dian, Qiming Venture Partners, Eli Lilly Asia Fund, Source Code Capital, and Shanghai Guotou Xian Dao continue to follow on. In the past year, Ladder Medical’s total financing has reached 1.1 billion RMB.

Founded in August 2021, Ladder Medical is an innovative tech company focused on implantable brain-computer interfaces. It aims to develop neural interfaces (electrodes), implantable brain-machine interface platforms, and translate related scientific research into clinical applications, targeting motor control, neural disease monitoring and regulation, and sensory perception restoration.

AicoPulse completes over 100 million RMB in Series B financing

On March 13, AicoPulse Medical Devices (Zhejiang) Co., Ltd. announced the completion of over 100 million RMB in funding, led by China International Capital Corporation’s funds, with Yuanjing Capital and well-known industry investors following, and Xingqiao Capital serving as exclusive financial advisor. The funds will mainly accelerate R&D and commercialization of pulse electric field ablation systems, 3D mapping systems, and series electrophysiology consumables, further strengthening its leading position in cardiac electrophysiology.

AicoPulse focuses on cardiac electrophysiology and structural heart disease intervention, aiming to become a leading global platform for electrophysiology innovation. The company has R&D centers in both China and the US, with core team members from Johnson & Johnson, Abbott, Medtronic, and other global leading companies, possessing strong technical and industrialization experience.

Technology and Manufacturing

Oka Smart Ship completes nearly 2 billion RMB in Series B+ financing

On March 9, Oka Smart Ship, a developer of surface unmanned vessels and surface service robots, announced nearly 2 billion RMB in Series B+ funding, led by Houxue Capital and Yuanhe Chongyuan. Previous investors include Gobi Bay Area and Tianshan Capital.

Oka Intelligence specializes in environmentally friendly surface unmanned ships, made from high-strength fiberglass composites with features such as corrosion resistance, wear resistance, and microwave transparency. Its vessels support applications like surface cleaning, water quality testing, water purification, surface inspection, and water area mapping.

Huaxin Cheng completes nearly 2 billion RMB in Series B+ financing

On March 9, Huaxin Cheng, a chip design service provider, announced over 3 billion RMB in Series A+ funding, invested by Pudong Venture Capital, Lingang Science and Technology Venture Capital, and Shanghai Integrated Circuit Industry Fund. Previous investors include Goxin Capital and SMIC Xicheng.

BlueStar Light Domain completes nearly 5 billion RMB in Series C financing

On March 10, BlueStar Light Domain, a satellite laser communication terminal developer, announced nearly 5 billion RMB in Series C funding, led by Yuekai Capital and Galaxy Innovation Capital. Previous investors include Xiyang Capital, Guoxin High-Level Talent Fund, and Guangzhou Industry Investment Fund.

Guanglun Intelligence completes 1 billion RMB in Series A+ financing

On March 11, Guanglun Intelligence, a generative AI and simulation data provider, announced 1 billion RMB in Series A+ funding, invested by New Hope Group and Dingbang Investment. Prior investors include Dongfang Fuhai and Sanqi Interactive Entertainment Venture Capital.

Founded in 2023, Guanglun Intelligence aims to provide automated, physically precise, controllable, realistic, and generalizable synthetic data solutions for enterprise AI deployment. It innovatively integrates generative AI with simulation technology to produce multimodal, high-quality, large-scale, low-cost synthetic data, addressing data gaps in the AI era.

Qianxing Innovation completes nearly 100 million RMB in Series C financing

On March 11, Shenzhen Qianxing Innovation Technology Co., Ltd. (Qianxing Innovation) announced nearly 100 million RMB in Series C funding, led by Liban Capital. The funds will be used for core technology R&D, key product iteration, supply chain and manufacturing upgrades, overseas market expansion, and industry scenario solution development.

Founded in 2016, Qianxing Innovation is a global underwater intelligent equipment company focusing on industry and consumer-grade underwater robots, portable underwater intelligent unmanned equipment, and related solutions. It is also a national “Little Giant” enterprise specializing in precision manufacturing.

AiShi Technology completes $300 million Series C financing

On March 12, AI video generation company AiShi Technology announced $300 million in Series C funding, led by Dinghui Hong Kong Fund, Dinghui VGC, and Dinghui Baifu, with industry investors China Ruyi, Sanqi Interactive Entertainment, and others including Youzhao GuoTou, Zhongwei Capital, and Guotai Junan Innovation Investment participating.

AiShi aims to build a visual multimodal algorithm platform focused on AIGC, covering various vertical visual application scenarios. The team intends to serve the entire content production value chain through AI video generation, enhancing efficiency in content creation, security, analysis, distribution, and commercialization, ultimately aiming to develop AI-native video products.

Zhongke Optoelectronics completes nearly 400 million RMB in Series A funding

On March 13, Zhongke Optoelectronics, an intelligent industrial robot company, announced nearly 400 million RMB in Series A funding, led by Donghai Investment and Baichuan Energy. Previous investors include Dongfang Jiafu and Shanda Investment.

Supported by the Xi’an Institute of Optics and Precision Engineering of the Chinese Academy of Sciences and Zhongke Chuangxing, the company’s core technical team originates from the Chinese Academy of Sciences. Using advanced mathematical theories and stereoscopic vision sensing, it has developed a new intelligent architecture to solve fine visual recognition of arbitrary artificial 3D objects.

Jizhan Power completes 2 billion RMB in Series A funding

On March 9, Jizhan Power announced a total of 2 billion RMB in Series A funding within less than half a year, with Yuanjing Capital, Lan Chi Venture Capital, and others participating. The funds will be mainly used for core technology R&D, product iteration, supply chain and manufacturing upgrades, and market expansion.

Founded in July 2025, Jizhan Power is an innovative technology company dedicated to high-value embodied intelligence products based on real-world scenarios, utilizing high-capacity unified models, efficient data loops, and reliable hardware to empower future human development.

MagicLab completes over 500 million RMB in Series A financing

On March 9, MagicLab, an embodied intelligence company, announced over 500 million RMB in Series A funding, with investors including Sky Venture Capital, Top Group, Jinyu Maowu, Suda Tiangong, Jiechuan Intelligence, Aishi Da, and Liang Venture Capital. Meanwhile, MagicLab’s ecosystem fund has established a presence in Wuxi, forming a “financing + fundraising” dual strategy around embodied intelligence applications, with a total capital scale exceeding 10.5 billion RMB, supporting ongoing R&D, product iteration, and industry ecosystem development to accelerate the industrialization of embodied intelligence.